Mettler-Toledo International
MTDNYSECIK 1037646Healthcare / Diagnostics & Researchfiscal year ends December69 quarters since 2009
Latest quarter Q2 FY2026, filed July 31, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
The last 16 quarters
Q3 FY2022 to Q2 FY2026, through the filing of July 31, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.
| Millions of dollars | Q2 FY2026ended Jun 30, 2026filed Jul 31, 2026 | Q1 FY2026ended Mar 31, 2026filed May 8, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 6, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025 | Q1 FY2025ended Mar 31, 2025filed May 2, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 7, 2025 | Q3 FY2024ended Sep 30, 2024filed Nov 8, 2024 | YoYQ2 FY2026vs Q2 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,027 | 947 | 1,130 | 1,030 | 983 | 884 | 1,045 | 955 | +4.5% |
| Cost of revenue | — | — | — | — | — | — | — | — | — |
| Gross profit | 650 | 556 | 675 | 609 | 580 | 526 | 639 | 572 | +12.1% |
| Research and development | 53 | 51 | 53 | 51 | 49 | 46 | 50 | 47 | +7.5% |
| Selling, general and administrative | 263 | 258 | 260 | 248 | 247 | 243 | 237 | 229 | +6.5% |
| Operating income | — | — | — | — | — | — | — | — | — |
| Other income (expense) | (2) | 7 | 8 | 3 | 3 | 3 | 1 | 2 | −172.3% |
| Pretax income | 289 | 210 | 329 | 269 | 249 | 202 | 315 | 259 | +16.4% |
| Income tax | 57 | 40 | 43 | 52 | 46 | 38 | 62 | 47 | +22.0% |
| Net income | 233 | 169 | 286 | 217 | 202 | 164 | 252 | 212 | +15.1% |
| Diluted EPS ($) | 11.55 | 8.33 | — | 10.57 | 9.76 | 7.81 | — | 9.96 | +18.3% |
| Diluted shares (millions) | 20 | 20 | — | 21 | 21 | 21 | — | 21 | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.
| Millions of dollars | Q2 FY2026ended Jun 30, 2026filed Jul 31, 2026 | Q1 FY2026ended Mar 31, 2026filed May 8, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 6, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025 | Q1 FY2025ended Mar 31, 2025filed May 2, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 7, 2025 | Q3 FY2024ended Sep 30, 2024filed Nov 8, 2024 | YoYQ2 FY2026vs Q2 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 51 | — | 67 | 69 | 62 | — | 59 | 72 | −16.9% |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | 1,347 | 1,332 | 1,363 | 1,281 | 1,244 | 1,165 | 1,194 | 1,198 | +8.3% |
| Total assets | 3,671 | 3,669 | 3,713 | 3,521 | 3,400 | 3,235 | 3,240 | 3,320 | +8.0% |
| Total current liabilities | 1,201 | 1,108 | 1,198 | 1,192 | 1,107 | 1,150 | 1,168 | 1,185 | +8.5% |
| Long-term debt | 2,045 | 2,162 | 2,088 | 2,146 | 2,124 | 1,891 | 1,831 | 1,892 | −3.7% |
| Total liabilities | 3,658 | 3,711 | 3,736 | 3,771 | 3,659 | 3,417 | 3,367 | 3,474 | −0.0% |
| Stockholders’ equity | 13 | (42) | (24) | (249) | (259) | (182) | (127) | (154) | +105.0% |
| Shares outstanding (millions) | 20 | 20 | 20 | 20 | 21 | 21 | 21 | 21 | — |
Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.
| Millions of dollars | Q2 FY2026ended Jun 30, 2026filed Jul 31, 2026 | Q1 FY2026ended Mar 31, 2026filed May 8, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 6, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025 | Q1 FY2025ended Mar 31, 2025filed May 2, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 7, 2025 | Q3 FY2024ended Sep 30, 2024filed Nov 8, 2024 | YoYQ2 FY2026vs Q2 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 310 | 140 | 226 | 299 | 236 | 194 | 266 | 255 | +31.3% |
| Capital expenditures | 28 | 17 | 42 | 24 | 24 | 17 | 41 | 21 | +16.4% |
| Free cash flow (CFO − capex) | 283 | 122 | 184 | 275 | 212 | 177 | 225 | 233 | +33.0% |
| Depreciation and amortization | — | — | — | — | — | — | — | — | — |
| Share repurchases | 206 | 206 | 144 | 219 | 219 | 219 | 213 | 212 | −5.7% |
| Dividends paid | — | — | — | — | — | — | — | — | — |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed February 6, 2026.
Income statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 6, 2026 | FY2024ended Dec 31, 2024filed Feb 7, 2025 | FY2023ended Dec 31, 2023filed Feb 9, 2024 | FY2022ended Dec 31, 2022filed Feb 10, 2023 | FY2021ended Dec 31, 2021filed Feb 11, 2022 | FY2020ended Dec 31, 2020filed Feb 8, 2021 | FY2019ended Dec 31, 2019filed Feb 7, 2020 | FY2018ended Dec 31, 2018filed Feb 8, 2019 | FY2017ended Dec 31, 2017filed Feb 9, 2018 | FY2016ended Dec 31, 2016filed Feb 2, 2017 | FY2015ended Dec 31, 2015filed Feb 4, 2016 | FY2014ended Dec 31, 2014filed Feb 6, 2015 | FY2013ended Dec 31, 2013filed Feb 7, 2014 | FY2012ended Dec 31, 2012filed Feb 8, 2013 | FY2011ended Dec 31, 2011filed Feb 13, 2012 | FY2010ended Dec 31, 2010filed Feb 16, 2011 | FY2009ended Dec 31, 2009filed Jul 23, 2010 | FY2008ended Dec 31, 2008filed Jul 23, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,026 | 3,872 | 3,788 | 3,920 | 3,718 | 3,085 | 3,009 | 2,936 | 2,725 | 2,508 | 2,395 | 2,486 | 2,379 | 2,342 | 2,309 | 1,968 | 1,729 | 1,973 |
| Cost of revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross profit | 2,391 | 2,326 | 2,241 | 2,308 | 2,172 | 1,801 | 1,741 | 1,684 | 1,576 | 1,438 | 1,352 | 1,359 | 1,282 | 1,241 | 1,218 | 1,037 | 889 | 993 |
| Research and development | 199 | 189 | 185 | 177 | 170 | 140 | 144 | 141 | 128 | 119 | 119 | 123 | 116 | 113 | 116 | 97 | 90 | 102 |
| Selling, general and administrative | 998 | 936 | 904 | 938 | 944 | 820 | 819 | 813 | 795 | 745 | 701 | 729 | 693 | 684 | 704 | 589 | 505 | 580 |
| Operating income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other income (expense) | 17 | 5 | 4 | 9 | 3 | 14 | 6 | 22 | 10 | 1 | 1 | (2) | (3) | (1) | (2) | (4) | (1) | (3) |
| Pretax income | 1,049 | 1,037 | 974 | 1,071 | 949 | 749 | 681 | 652 | 574 | 504 | 463 | 445 | 403 | 383 | 349 | 308 | 225 | 266 |
| Income tax | 180 | 174 | 185 | 198 | 180 | 146 | 120 | 139 | 198 | 120 | 111 | 107 | 97 | 92 | 80 | 75 | 52 | 63 |
| Net income | 869 | 863 | 789 | 873 | 769 | 603 | 561 | 513 | 376 | 384 | 353 | 338 | 306 | 291 | 269 | 232 | 173 | 203 |
| Diluted EPS ($) | 42.05 | 40.48 | 35.90 | 38.41 | 32.78 | 24.91 | 22.47 | 19.88 | 14.24 | 14.22 | 12.48 | 11.44 | 9.96 | 9.14 | 8.21 | 6.80 | 5.03 | 5.79 |
| Diluted shares (millions) | 21 | 21 | 22 | 23 | 23 | 24 | 25 | 26 | 26 | 27 | 28 | 30 | 31 | 32 | 33 | 34 | 34 | 35 |
Balance sheet
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 6, 2026 | FY2024ended Dec 31, 2024filed Feb 7, 2025 | FY2023ended Dec 31, 2023filed Feb 9, 2024 | FY2022ended Dec 31, 2022filed Feb 10, 2023 | FY2021ended Dec 31, 2021filed Feb 11, 2022 | FY2020ended Dec 31, 2020filed Feb 8, 2021 | FY2019ended Dec 31, 2019filed Feb 7, 2020 | FY2018ended Dec 31, 2018filed Feb 8, 2019 | FY2017ended Dec 31, 2017filed Feb 9, 2018 | FY2016ended Dec 31, 2016filed Feb 2, 2017 | FY2015ended Dec 31, 2015filed Feb 4, 2016 | FY2014ended Dec 31, 2014filed Feb 6, 2015 | FY2013ended Dec 31, 2013filed Feb 7, 2014 | FY2012ended Dec 31, 2012filed Feb 8, 2013 | FY2011ended Dec 31, 2011filed Feb 13, 2012 | FY2010ended Dec 31, 2010filed Feb 16, 2011 | FY2009ended Dec 31, 2009filed Jul 23, 2010 | FY2008ended Dec 31, 2008filed Jul 23, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 67 | 59 | 70 | 96 | 99 | 94 | 208 | 178 | 149 | 159 | 99 | 85 | 112 | 102 | 236 | 448 | 85 | 78 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current assets | 1,363 | 1,194 | 1,230 | 1,375 | 1,269 | 1,057 | 1,110 | 1,046 | 1,007 | 897 | 795 | 849 | 914 | 864 | 1,019 | 1,145 | 646 | — |
| Total assets | 3,713 | 3,240 | 3,356 | 3,492 | 3,327 | 2,815 | 2,789 | 2,619 | 2,550 | 2,167 | 1,959 | 1,974 | 2,153 | 2,022 | 2,115 | 2,283 | 1,719 | — |
| Total current liabilities | 1,198 | 1,168 | 1,181 | 1,148 | 1,147 | 840 | 755 | 734 | 690 | 588 | 558 | 679 | 564 | 562 | 610 | 542 | 495 | — |
| Long-term debt | 2,088 | 1,831 | 1,889 | 1,908 | 1,581 | 1,284 | 1,235 | 985 | 960 | 875 | 575 | 336 | 396 | 347 | 477 | 670 | 204 | — |
| Total liabilities | 3,736 | 3,367 | 3,505 | 3,468 | 3,155 | 2,532 | 2,369 | 2,029 | 2,003 | 1,732 | 1,379 | 1,290 | 1,218 | 1,195 | 1,422 | 1,511 | 1,008 | — |
| Stockholders’ equity | (24) | (127) | (150) | 25 | 171 | 283 | 421 | 590 | 547 | 435 | 580 | 720 | 935 | 827 | 781 | 772 | 711 | 503 |
| Shares outstanding (millions) | 20 | 21 | 21 | 22 | 23 | 23 | 24 | 25 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | — | — |
Cash flow statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 6, 2026 | FY2024ended Dec 31, 2024filed Feb 7, 2025 | FY2023ended Dec 31, 2023filed Feb 9, 2024 | FY2022ended Dec 31, 2022filed Feb 10, 2023 | FY2021ended Dec 31, 2021filed Feb 11, 2022 | FY2020ended Dec 31, 2020filed Feb 8, 2021 | FY2019ended Dec 31, 2019filed Feb 7, 2020 | FY2018ended Dec 31, 2018filed Feb 8, 2019 | FY2017ended Dec 31, 2017filed Feb 9, 2018 | FY2016ended Dec 31, 2016filed Feb 2, 2017 | FY2015ended Dec 31, 2015filed Feb 4, 2016 | FY2014ended Dec 31, 2014filed Feb 6, 2015 | FY2013ended Dec 31, 2013filed Feb 7, 2014 | FY2012ended Dec 31, 2012filed Feb 8, 2013 | FY2011ended Dec 31, 2011filed Feb 13, 2012 | FY2010ended Dec 31, 2010filed Feb 16, 2011 | FY2009ended Dec 31, 2009filed Jul 23, 2010 | FY2008ended Dec 31, 2008filed Jul 23, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 956 | 968 | 966 | 859 | 909 | 725 | 603 | 565 | 516 | 461 | 440 | 419 | 346 | 328 | 281 | 268 | 233 | 223 |
| Capital expenditures | 107 | 104 | 105 | 121 | 108 | 92 | 97 | 143 | 127 | 124 | 83 | 89 | 82 | 96 | 99 | 74 | 60 | 61 |
| Free cash flow (CFO − capex) | 849 | 864 | 861 | 738 | 801 | 632 | 506 | 422 | 389 | 337 | 357 | 330 | 264 | 232 | 182 | 194 | 173 | 162 |
| Depreciation and amortization | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | 800 | 850 | 900 | 1,100 | 1,000 | 775 | 775 | 475 | 400 | 500 | 495 | 414 | 295 | 279 | 205 | 240 | 6 | 230 |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Shuman-Fabbri Natalia | Director | award | 16 | $0.00 | — | 16 | Sep 1, 2026 |
| Aug 27, 2026 | Kaltenbach Patrick | President and CEO | option exercise | 942 | $1024.55 | $965K | 5,422 | Aug 31, 2026 |
| Aug 27, 2026 | Kaltenbach Patrick | President and CEO | open-market sale | 942 | $1425.00 | $1M | 4,480 | Aug 31, 2026 |
| Aug 5, 2026 | Salice Thomas P | Director | option exercise | 417 | $397.95 | $166K | 709 | Aug 7, 2026 |
| Aug 5, 2026 | Salice Thomas P | Director | open-market sale | 417 | $1440.41 | $601K | 292 | Aug 7, 2026 |
| Aug 3, 2026 | Salice Thomas P | Director | option exercise | 415 | $397.95 | $165K | 707 | Aug 5, 2026 |
| Aug 3, 2026 | Salice Thomas P | Director | open-market sale | 415 | $1444.62 | $600K | 292 | Aug 5, 2026 |
| Aug 3, 2026 | Keller Gerry | Head of Process Analytics | option exercise | 240 | $720.81 | $173K | 499 | Aug 5, 2026 |
| Aug 3, 2026 | Keller Gerry | Head of Process Analytics | open-market sale | 240 | $1427.14 | $343K | 259 | Aug 5, 2026 |
| Aug 3, 2026 | Vadala Shawn | Chief Financial Officer | option exercise | 2,240 | $595.31 | $1M | 7,819 | Aug 5, 2026 |
| Aug 3, 2026 | Vadala Shawn | Chief Financial Officer | open-market sale | 2,240 | $1432.00 | $3M | 5,579 | Aug 5, 2026 |
| May 12, 2026 | Wong Ann Ping Richard | Head of Asia & Pacific | award | 103 | $0.00 | — | 645 | May 14, 2026 |
| May 12, 2026 | Wittorf Oliver | Head of PI, Retail, and GSC | award | 87 | $0.00 | — | 495 | May 14, 2026 |
| May 12, 2026 | Vadala Shawn | Chief Financial Officer | award | 291 | $0.00 | — | 5,579 | May 14, 2026 |
| May 12, 2026 | Keller Gerry | Head of Process Analytics | award | 100 | $0.00 | — | 259 | May 14, 2026 |
| May 12, 2026 | Kaltenbach Patrick | President and CEO | award | 810 | $0.00 | — | 4,480 | May 14, 2026 |
| May 12, 2026 | Graham-Bryce Susan | Chief Human Resources Officer | award | 71 | $0.00 | — | 517 | May 14, 2026 |
| Feb 17, 2026 | Tokich Michael J | Director | award | 50 | $0.00 | — | 50 | Feb 19, 2026 |
| Feb 10, 2026 | Vadala Shawn | Chief Financial Officer | open-market sale | 800 | $1410.12 | $1M | 5,288 | Feb 11, 2026 |
| Feb 10, 2026 | Vadala Shawn | Chief Financial Officer | option exercise | 800 | $595.31 | $476K | 6,088 | Feb 11, 2026 |
| Nov 25, 2025 | de la Guerroniere Marc | Head of Eur & NA Market Orgs | option exercise | 2,475 | $1103.74 | $3M | 6,242 | Nov 26, 2025 |
| Nov 25, 2025 | de la Guerroniere Marc | Head of Eur & NA Market Orgs | open-market sale | 3,580 | $1480.00 | $5M | 2,662 | Nov 26, 2025 |
| Nov 25, 2025 | de la Guerroniere Marc | Head of Eur & NA Market Orgs | open-market sale | 2,475 | $1500.00 | $4M | 187 | Nov 26, 2025 |
| Nov 25, 2025 | de la Guerroniere Marc | Head of Eur & NA Market Orgs | option exercise | 3,580 | $720.81 | $3M | 3,767 | Nov 26, 2025 |
| Nov 25, 2025 | Vadala Shawn | Chief Financial Officer | open-market sale | 1,000 | $1511.00 | $2M | 5,288 | Nov 26, 2025 |
Full insider history for Mettler-Toledo International, or insider activity across all companies. A record of filings, not a recommendation.
Tracked funds holding it
1 of the tracked managers held MTD in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded MTD by quarter.
| Fund | Manager | Quarter | Value | Shares | Weight | Move |
|---|---|---|---|---|---|---|
| Baron Capital Group | Ron Baron | Q2 2026 | $177M | 138,464 | 0.27% | added +3.6% |
Sources
Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- Mettler-Toledo International Inc., CIK 1037646 on EDGAR
- Extract generated
- October 6, 2026
- Withheld
- 7 line-years whose four quarters do not sum to the filed year: gross profit FY2010, net income FY2010, revenue FY2010, revenue FY2011, net income FY2020, net income FY2021, net income FY2022
- Repaired
- none
XBRL concepts behind each line
Income statement
RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNetGrossProfitResearchAndDevelopmentExpenseSellingGeneralAndAdministrativeExpenseOtherNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueAssetsCurrentAssetsLiabilitiesCurrentLongTermDebtNoncurrentLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquirePropertyPlantAndEquipmentPaymentsForRepurchaseOfCommonStockThe data
The statements on this page as files, generated October 6, 2026.
- JSON file
/data/financials/MTD.json